These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34326699)

  • 21. The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases.
    Wu X; Chen H; Li K; Zhang H; Li K; Tan H
    J Transl Med; 2024 May; 22(1):490. PubMed ID: 38790013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
    Zhang G; Miao F; Liu K; Wu J; Xu J
    Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
    Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression.
    Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X
    FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEST promotes lung cancer invasion and metastasis by interacting with VCP to activate NF-κB signaling.
    Wang Y; Zhang J; Li YJ; Yu NN; Liu WT; Liang JZ; Xu WW; Sun ZH; Li B; He QY
    J Exp Clin Cancer Res; 2021 Sep; 40(1):301. PubMed ID: 34560900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression.
    Ling T; Yu F; Cao H
    Oncol Rep; 2018 Dec; 40(6):3705-3713. PubMed ID: 30542706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated.
    Tanabe A; Tanikawa K; Tsunetomi M; Takai K; Ikeda H; Konno J; Torigoe T; Maeda H; Kutomi G; Okita K; Mori M; Sahara H
    Cancer Lett; 2016 Jun; 376(1):34-42. PubMed ID: 26996300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
    Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
    J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N
    Zhou B; Liu C; Xu L; Yuan Y; Zhao J; Zhao W; Chen Y; Qiu J; Meng M; Zheng Y; Wang D; Gao X; Li X; Zhao Q; Wei X; Wu D; Zhang H; Hu C; Zhuo X; Zheng M; Wang H; Lu Y; Ma X
    Hepatology; 2021 Jan; 73(1):91-103. PubMed ID: 32150756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
    Zhang LM; Zhou JJ; Luo CL
    Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
    Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
    Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
    Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
    Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling.
    Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W
    J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA CALML3-AS1 modulated by m
    Zhang H; Wang SQ; Zhu JB; Wang LN; Lin H; Li LF; Cheng YD; Duan CJ; Zhang CF
    Cancer Gene Ther; 2023 Dec; 30(12):1649-1662. PubMed ID: 37884580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNAJC12 promotes lung cancer growth by regulating the activation of β‑catenin.
    Li Y; Li M; Jin F; Liu J; Chen M; Yin J
    Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
    Yan L; He Z; Li W; Liu N; Gao S
    Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.